CFMS

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Conformis Inc.

Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which Conformis refers to as personalized, individualized, or sometimes as customized, to fit each patient's unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers. In clinical studies, the Conformis iTotal® CR knee replacement system demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
CEO
Employees
259
Headquarters

News

Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
Nov 21, 2022 10:58am

Gainers AGBA Group Holding Limited (NASDAQ: AGBA ) gained 50.7% to close at $6.78 on Friday. FOXO Technologies Inc. (NYSE: FOXO ) shares surged 46.9% to close at $0.6520 on Friday. Foxo Technologies recently announced management changes and delayed filing of Form 10Q. PaxMedica, Inc. (NASDAQ: PXMD ) jumped 37.4% to close at $2.13 on Friday after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital. Mercurity Fintech Holding Inc. (NASDAQ: MFH ) gained 32.9% to close at $1.05. Yatra Online, Inc. (NASDAQ: YTRA ) shares surged 32.6% to close at $2.81. Yatra Online''s Indian subsidiary, Yatra Online Limited, received the final observation from the Securities and Exchange Board of India. The company also announced that it will report its Q2 financial results on Tuesday, November 29, 2022. Stryve Foods, Inc. (NASDAQ: SNAX ) gained 28.6% to settle at $0.6431. Stryve Foods recently reported worse-than-expected Q3 sales results. Conformis, Inc. (NASDAQ: CFMS ) rose 28.5% to close at $2.03.


Source:Benzinga
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday''s Mid-Day Session
Nov 18, 2022 18:15pm

Gainers PaxMedica, Inc. (NASDAQ: PXMD ) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital. Satixfy Communications Ltd. (NYSE: SATX ) rose 53.2% to $79.20. 1847 Holdings LLC (NYSE: EFSH ) gained 27.3% to $2.0252. 1847 Holdings recently posted Q3 sales of $14.47 million. IVERIC bio, Inc. (NASDAQ: ISEE ) shares surged 25% to $21.54 after the company announced the FDA has granted breakthrough therapy designation for avacincaptad pegol for geographic atrophy. Clearfield, Inc. (NASDAQ: CLFD ) climbed 24.1% to $115.45 after the company reported better-than-expected Q4 results. Yatra Online, Inc. (NASDAQ: YTRA ) shares jumped 24.1% to $2.6299. Yatra Online''s Indian subsidiary, Yatra Online Limited, received the final observation from the Securities and Exchange Board of India. The company also announced that it will report its Q2 financial results on Tuesday, November 29, 2022. Conformis, Inc. (NASDAQ: CFMS ) gained 23.6% to $1.9540.


Source:Benzinga
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Nov 18, 2022 10:14am

Gainers Satixfy Communications Ltd. (NYSE: SATX ) jumped 96.4% to settle at $51.70 on Thursday. Elevate Credit, Inc. (NYSE: ELVT ) shares jumped 68.9% to close at $1.79 on Thursday after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million. Ardelyx Inc (NASDAQ: ARDX ) shares climbed 41% to close at $1.72 as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis. CytomX Therapeutics, Inc. (NASDAQ: CTMX ) gained 32.2% to close at $1.60 after the company and Regeneron announced a strategic research collaboration in the field of conditional bispecific therapeutics for the treatment of cancer. Atour Lifestyle Holdings Limited (NASDAQ: ATAT ) climbed 31% to close at $14.92. NWTN Inc. (NASDAQ: NWTN ) gained 29.8% to settle at $4.10. Cuentas Inc. (NASDAQ: CUEN ) jumped 28% to close at $0.32 after dropping 28% on Wednesday.


Source:Benzinga
Conformis Announces Full Commercial Launch of Imprint
Nov 17, 2022 12:00pm

Conformis’ Imprint knee system introduces the new “Made-to-Measure” product category option for Total Knee Arthroplasty (TKA) BILLERICA, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced the full commercial launch of its new Imprint knee system. This launch


Source:Wallstreet:Online
Conformis Announces Full Commercial Launch of Imprint™
Nov 17, 2022 12:00pm

Conformis’ Imprint™ knee system introduces the new “Made-to-Measure” product category option for Total Knee Arthroplasty (TKA) Conformis’ Imprint™ knee system introduces the new “Made-to-Measure” product category option for Total Knee Arthroplasty (TKA)


Source:GlobeNewswire
Conformis Inc. (NASDAQ: CFMS) Is Down -16.24% – Can It Revive?
Nov 09, 2022 21:00pm

Conformis Inc. (NASDAQ:CFMS) price is hovering lower on Wednesday, November 09, dropping -16.24% below its previous close. A look at today’s price movement shows that the recent level at last check reads $0.10, with intraday deals fluctuating between $0.0967 and $0.1102. The company’s 5Y monthly beta was ticking 1.46. Taking into account the 52-week price … Conformis Inc. (NASDAQ: CFMS) Is Down -16.24% – Can It Revive? Read More »


Source:Stocks Register
Conformis implements 1-for-25 reverse stock split
Nov 09, 2022 12:23pm

Medical technology company Conformis (CFMS) has implemented a 1-for-25 reverse stock split. Its common stock will begin trade on the Nasdaq Capital Market on a split-adjusted basis on…


Source:Seeking Alpha
The Behavior Of Conformis Inc. (CFMS) Stock Is Not As Predictable As You Think
Nov 04, 2022 14:30pm

Conformis Inc. (NASDAQ:CFMS) concluded the trading at $0.11 on Thursday, November 03 with a fall of -7.48% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.12 and 5Y monthly beta was reading 1.46 with its price kept floating in the range … The Behavior Of Conformis Inc. (CFMS) Stock Is Not As Predictable As You Think Read More »


Source:Stocks Register
Conformis, Inc. (CFMS) Q3 2022 Earnings Call Transcript
Nov 03, 2022 01:59am

Conformis, Inc. (NASDAQ:NASDAQ:CFMS) Q3 2022 Results Conference Call November 02, 2022 04:30 PM ET Company Participants Mark Augusti - President and CEO Bob Howe - CFO and Treasurer…


Source:Seeking Alpha
ConforMIS Inc Earnings, Revenue Miss in Q3 By Investing.com
Nov 02, 2022 23:13pm

ConforMIS Inc Earnings, Revenue Miss in Q3


Source:Investing.com
ConforMIS GAAP EPS of -$0.08 misses by $0.01, revenue of $13.8M beats by $0.08M (NASDAQ:CFMS)
Nov 02, 2022 21:30pm

ConforMIS press release (CFMS): Q3 GAAP EPS of -$0.08 misses by $0.01.Revenue of $13.8M (-3.2% Y/Y) beats by $0.08M.Product revenue of $13.6 million, a decrease of 3% year-over-year…


Source:Seeking Alpha
ConforMIS Inc Misses Q3 EPS by 1c By Investing.com
Nov 02, 2022 20:24pm

ConforMIS Inc Misses Q3 EPS by 1c


Source:Investing.com
Conformis Reports Third Quarter 2022 Financial Results
Nov 02, 2022 20:10pm

BILLERICA, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the third quarter ended September 30, 2022.


Source:GlobeNewswire
Investing in Conformis Inc. (CFMS) might be a great opportunity, but the stock is a bit undervalued
Oct 31, 2022 14:08pm

A share of Conformis Inc. (NASDAQ:CFMS) closed at $0.12 per share on Friday, down from $0.12 day before. While Conformis Inc. has underperformed by -0.08%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CFMS fell by -90.08%, with highs and lows ranging from $1.25 to $0.11, […]


Source:US Post News
Here Is How Powerful Conformis Inc. (NASDAQ: CFMS) Stock Is
Oct 25, 2022 13:30pm

The trading price of Conformis Inc. (NASDAQ:CFMS) closed lower on Monday, October 24, closing at $0.11, -4.45% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $0.1075 and $0.1137. In examining the 52-week price action we see that the stock hit a 52-week high … Here Is How Powerful Conformis Inc. (NASDAQ: CFMS) Stock Is Read More »


Source:Stocks Register
Conformis, Inc. to Announce Financial Results for Its Third Quarter 2022
Oct 05, 2022 20:30pm

BILLERICA, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the third quarter ended September 30, 2022, after the market closes on Wednesday, November 2, 2022.


Source:GlobeNewswire
Conformis Inc. (NASDAQ: CFMS) Has Succeeded In Gaining Momentum In 2022, The Stock Is Down -74.89% YTD
Oct 01, 2022 12:30pm

Conformis Inc. (NASDAQ:CFMS)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting 1.22. At the close of trading, the stock’s price was $0.19, to imply a decrease of -10.99% or -$0.02 in intraday trading. The CFMS share’s 52-week high remains $1.36, putting it -615.79% down since that peak … Conformis Inc. (NASDAQ: CFMS) Has Succeeded In Gaining Momentum In 2022, The Stock Is Down -74.89% YTD Read More »


Source:Marketing Sentinel